Cancer
CD22 antigen 459-467 (HLA-A*02:01) SLPYHSQKL
Product number: EP07884_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
D22 antigen(459-467) peptide SLPYHSQKL (HLA- A*02:01) for stimulation of T-cells. Single peptide (SLPYHSQKL) for stimulation of human CD22 antigen(459-467)-specific CD8+ T-cells.
TechData
| Sequence: | SLPYHSQKL |
| Gene: | MS4A1 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | B-lymphocyte antigen CD20 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer, Neuroscience, Autoimmune disease |
| Purity: | 95% HPLC-MS |